CEVR analyzes the value of strategies to improve health and health care.

About Us

News

Unique Applications of the CEA Registry in 2024
Grace Hatfield In 2024, researchers used the CEA Registry to support more than 60 research articles. Topics ranged from cost-effectiveness analyses of...
Read more April 14, 2025
7th Annual Tufts-CEVR’s Cost-Effectiveness Paper of the Year Award Winners
The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center is pleased to announce the winners of our 7th annual Paper of...
Read more April 8, 2025
The Death of QALYs is Greatly Exaggerated
The death of QALYs is greatly exaggerated Peter J. Neumann The QALY has taken a licking but keeps on ticking. The US Congress has prohibited its use ...
Read more March 17, 2025
View All News Items

Events

CEVR Health Policy Seminar with Xin Hu, PhD, MSPH
Learn more
2:00–3:00 on April 22, 2025
CEVR Health Policy Seminar with Aryana Sepassi, PharmD, MAS
Learn more
1:00–2:00 on March 26, 2025
CEVR Health Policy Seminar with David D. Kim, PhD
Learn more
3:00–4:00 on February 11, 2025
View All Events

Recent Publications

International Journal of Technology Assessment in Health Care
Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum
View publication
November 4, 2024
Health Affairs
Small-molecule drugs offer comparable health benefits to biologics at lower costs
View publication
November 1, 2024
STAT
Medicare’s new transitional coverage of emerging technologies program doesn’t go far enough
View publication
August 28, 2024
Value in Health
Does real option value influence oncologists' treatment recommendations? A survey of US oncologists
View publication
December 27, 2024
Value in Health
The health benefits, costs, and cost-effectiveness of ultraorphan drugs
View publication
July 31, 2024
Health Affairs Forefront
Improving how CMS defines “unmet medical need” under the IRA
View publication
July 30, 2024
Archives of Dermatological Research
Impact on quality of life, health care access, and health care utilization of individuals with vitiligo: an analysis of the All of Us Research Program
View publication
November 26, 2024
JAMA Network Open
Modeling the population equity of Alzheimer Disease treatments in the US
View publication
October 31, 2024
View All Publications

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.

CEA Registry

The CEA Registry is a comprehensive database of 9,080 cost-utility analyses on a wide variety of diseases and treatments.

View Registry

Global Health CEA Registry

The GH CEA Registry is the first comprehensive database to compile articles utilizing the “cost-per-DALY averted” metric to measure the efficacy of health interventions.

View Registry

SPEC Database

The Specialty Drug Evidence and Coverage (SPEC) Database is a new data resource developed with the goal of providing an empirical basis to commercial payer specialty drug coverage.

View Database
Learn About Our Databases